Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study

BACKGROUND: Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) infection is associated with hypercoagulability caused by direct invasion of endothelial cells and\or proinflammatory cytokine release. Thromboprophylaxis with enoxaparin is recommended by current guidelines, but evidence is st...

詳細記述

保存先:
書誌詳細
出版年:EClinicalMedicine
主要な著者: Albani, Filippo, Sepe, Lilia, Fusina, Federica, Prezioso, Chiara, Baronio, Manuela, Caminiti, Federica, Di Maio, Antonella, Faggian, Barbara, Franceschetti, Maria Elena, Massari, Marco, Salvaggio, Marcello, Natalini, Giuseppe
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier 2020
主題:
Research paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7534836/
https://ncbi.nlm.nih.gov/pubmed/33043287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2020.100562
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料